High expression of CD70, a protein belonging to the tumor necrosis family, was reported in TETs, and CD70-targeted CAR T cells were confirmed both in vitro and in vivo to be effective against tumors, indicating the possibility of CD70-targeted CAR T cell therapy for TETs [20–22]. The gene discussed is CD70; the disease is neoplasm.